İskemik İnme Tedavisi

Atilla Özcan Özdemir, Bijen Nazlıel, Ethem Murat Arsava, Hadiye Şirin, Levent Güngör, Mehmet Akif Topçuoğlu, et al. Akut İskemik İnme Tanı ve Tedavi Rehberi . 1st ed. Tecirli G, editor. Vol. 1. Ankara; 2020. 1–3 p.

Powers WJ, Rabinstein AA, Ackerson T et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec 1 [cited 2025 Jul 15];50(12):E344–418.

Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14 [cited 2025 May 18];333(24):1581–8.

Jauch EC, Cucchiara B, Adeoye O et al. Part 11: Adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2 [cited 2025 May 22];122(SUPPL. 3).

De La Ossa NP, Carrera D, Gorchs M et al. Design and validation of a prehospital stroke scale to predict large arterial occlusion : The rapid arterial occlusion evaluation scale. Stroke 2014 Jan [cited 2025 May 22];45(1):87–91.

Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000 May 13 [cited 2025 May 22];355(9216):1670–4.

Campbell BCV, Mitchell PJ, Kleinig TJ et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. New England Journal of Medicine 2015 Mar 12 [cited 2025 May 22];372(11):1009–18.

Campbell BCV, Ma H, Ringleb PA et al. Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. The Lancet. 2019 Jul 13 [cited 2025 May 22];394(10193):139–47.

Nogueira RG, Jadhav AP, Haussen DC et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. New England Journal of Medicine. 2018 Jan 4 [cited 2025 May 22];378(1):11–21.

Campbell BCV, Mitchell PJ, Churilov L et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. New England Journal of Medicine. 2018 Apr 26 [cited 2025 May 22];378(17):1573–82.

Parsons M, Spratt N, Bivard A et al. A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke. New England Journal of Medicine. 2012 Mar 22 [cited 2025 May 22];366(12):1099–107.

Logallo N, Novotny V, Assmus J et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017 Oct 1 [cited 2025 May 22];16(10):781–8.

Burgos AM, Saver JL. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials. Stroke. 2019 Aug 1 [cited 2025 May 22];50(8):2156–62.

Higashida RT, Furlan AJ, Roberts H et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke; a journal of cerebral circulation. 2003 [cited 2025 May 22];34(8).

Pożarowszczyk N, Kurkowska-Jastrzębska I et al. Reliability of the modified Rankin Scale in clinical practice of stroke units and rehabilitation wards. Front Neurol. 2023 [cited 2025 May 22];14:1064642.

Broderick JP, Adeoye O, Elm J. The Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017 Jul 1 [cited 2025 May 22];48(7):2007.

Bösel J, Niesen WD, Salih F et al. Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial. JAMA - Journal of the American Medical Association. 2022 May 17 [cited 2025 May 30];327(19):1899–909.

Bommena S, Rangan P, Lee-Iannotti J et al. Timing and Outcomes of Percutaneous Endoscopic Gastrostomy After Ischemic Stroke. Gastroenterology Res. 2023 Dec [cited 2025 May 30];16(6):281–8.

Bösel J, Niesen WD, Salih F et al. Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial. JAMA. 2022 May 1 [cited 2025 Jul 15];327(19):1899–909.

Bommena S, Rangan P, Lee-Iannotti J et al. Timing and Outcomes of Percutaneous Endoscopic Gastrostomy After Ischemic Stroke. Gastroenterology Res. 2023 Dec [cited 2025 Jul 15];16(6):281–8.

Mayer SA, Kurtz P, Wyman A et al. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: The Studying the Treatment of Acute hyperTension registry. Crit Care Med. 2011 [cited 2025 May 30];39(10):2330–6.

Powers WJ, Rabinstein AA, Ackerson T et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar 1 [cited 2025 May 30];49(3):e46–110.

Rasmussen M, Schönenberger S, Hendèn PL et al. Blood Pressure Thresholds and Neurologic Outcomes after Endovascular Therapy for Acute Ischemic Stroke: An Analysis of Individual Patient Data from 3 Randomized Clinical Trials. JAMA Neurol. 2020 May 1 [cited 2025 May 30];77(5):622–31.

Blech B, Chong BW, Sands KA et al. Are postprocedural blood pressure goals associated with clinical outcome after mechanical thrombectomy for acute ischemic stroke? Neurologist. 2019 Jan 1 [cited 2025 May 30];24(1):44–7.

Johnston KC, Bruno A, Pauls Q et al. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients with Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA - Journal of the American Medical Association. 2019 Jul 23 [cited 2025 May 30];322(4):326–35.

Hofmeijer J, Algra A, Kappelle LJ et al. Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovascular Diseases. 2008 Feb [cited 2025 May 30];25(1–2):176–84.

Vahedi K, Vicaut E, Mateo J et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007 Sep [cited 2025 May 30];38(9):2506–17.

Jüttler E, Schwab S, Schmiedek P et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): A randomized, controlled trial. Stroke. 2007 Sep [cited 2025 May 30];38(9):2518–25.

Jüttler E, Unterberg A, Woitzik J et al. Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke. New England Journal of Medicine. 2014 Mar 20 [cited 2025 May 30];370(12):1091–100.

Beez T, Munoz-Bendix C, Steiger HJ, Beseoglu K. Decompressive craniectomy for acute ischemic stroke. Crit Care. 2019 Jun 7 [cited 2025 Jul 15];23(1).

Diringer MN, Scalfani MT, Zazulia AR et al. Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. Neurocrit Care. 2011 Feb [cited 2025 May 30];14(1):11–7

Ziai WC, Toung TJK, Bhardwaj A. Hypertonic saline: First-line therapy for cerebral edema? J Neurol Sci. 2007 Oct 15 [cited 2025 May 30];261(1–2):157–66.

Love BB, Bendixen BH. Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke. 1993 [cited 2025 May 30];24(1):35–41.

Barer D, Cohen A, Bradford AP et al. Interpretation of IST and CAST stroke trials (multiple letters) [9]. Lancet. 1997 Aug 9 [cited 2025 May 30];350(9075):440–4.

Wang Y, Wang Y, Zhao X et al. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack. New England Journal of Medicine. 2013 Jul 4 [cited 2025 May 30];369(1):11–9.

Chen ZM, Sandercock P, Pan HC et al. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke. 2000 [cited 2025 May 30];31(6):1240

Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study. Lancet. 2000 Apr 8 [cited 2025 May 30];355(9211):1205–10.

Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: The case for a new clinical construct. Lancet Neurol. 2014 [cited 2025 May 30];13(4):429–38.

Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004 Jun 15 [cited 2025 May 30];109(23 SUPPL.).

P A, J B, A C et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 Aug 10 [cited 2025 May 30];355(6):549–59.

Amarenco P, Kim JS, Labreuche J et al. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. New England Journal of Medicine. 2020 Jan 2 [cited 2025 May 30];382(1):9–19.

Acar B, Akpınar ÇK, Alioglu Z et al. Use of NOAC in clinical practice of stroke: Expert Opinion of the Turkish Society of Cerebrovascular Diseases. Turkish Journal of Cerebrovascular Diseases. 2020;26(3):190–235.

Fuster V, Rydén LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary a report of the american college of cardiology/american heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol. 2001 [cited 2025 Jul 15];38(4):1231–65.

Olesen JB, Lip GYH, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ. 2011 Feb 5 [cited 2025 Jul 15];342(7792):320.

Hindricks G, Potpara T, Kirchhof P et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J [Internet]. 2021 Feb 1 [cited 2025 Jul 15];42(5):373–498.

Pisters R, Lane DA, Nieuwlaat R et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey. Chest. 2010 Nov 1 [cited 2025 Jul 15];138(5):1093–100.

Hart RG, Catanese L, Perera KS et al. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017 Apr 1 [cited 2025 Jul 15];48(4):867–72.

Perera KS, Vanassche T, Bosch J et al. Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. International Journal of Stroke. 2016 Jul 1 [cited 2025 Jul 15];11(5):526–33.

Hart RG, Sharma M, Mundl H et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. New England Journal of Medicine. 2018 Jun 7 [cited 2025 Jul 15];378(23):2191–201.

Diener HC, Sacco RL, Easton JD et al. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. New England Journal of Medicine. 2019 May 16 [cited 2025 Jul 15];380(20):1906–17.

Kamel H, Longstreth T, Tirschwell DL et al. Apixaban to Prevent Recurrence after Cryptogenic Stroke in Patients with Atrial Cardiopathy the ARCADIA Randomized Clinical Trial. JAMA. 2024 Feb 20 [cited 2025 Jul 15];331(7):573–81.

Geisler T, Keller T, Martus P et al. Apixaban versus Aspirin for Embolic Stroke of Undetermined Source. NEJM evidence. 2024 Dec 26 [cited 2025 Jul 15];3(1).

Beyer-Westendorf J, Michalski F, Tittl L et al. Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemost. 2016 Oct 1 [cited 2025 Jul 15];116(4):651–8.

Areia AL, Mota-Pinto A. Experience with direct oral anticoagulants in pregnancy - A systematic review. J Perinat Med. 2022 May 1 [cited 2025 Jul 15];50(4):457–61.

Bushnell C, Kernan WN, Sharrief AZ et al. 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2024 Oct 21 [cited 2025 Jun 8];55(12).

Naylor R, Rantner B, Ancetti S et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. European Journal of Vascular and Endovascular Surgery. 2023 Jan 1 [cited 2025 Jun 8];65(1):7–111.

Spiliopoulos S, Blanc R, Gandini R, et al. CIRSE Standards of Practice on Carotid Artery Stenting. Cardiovasc Intervent Radiol. 2024 Jun 1 [cited 2025 Jun 8];47(6):705–16.

Psychogios M, Brehm A, López-Cancio E et al. European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease. Eur Stroke J. 2022 Sep 1 [cited 2025 Jun 8];7(3):III–IV.

Bernhardt J, Langhorne P, Lindley RI et al. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): A randomised controlled trial. The Lancet. 2015 Jul 4 [cited 2025 Jul 15];386(9988):46–55.

Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. The Lancet. 2011 [cited 2025 Jul 15];377(9778):1693–702.